MedTrace Logo

Group Music Therapy for Emotional Well-Being and Social Connectedness

NCT07393581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-02-06

No results posted yet for this study

Summary

This randomized controlled trial evaluated whether two formats of group music therapy can improve emotional well-being, self-rated health, and social connectedness among undergraduate students living in urban areas in China. A total of 120 students were randomly assigned to one of three conditions: (1) active group music therapy, (2) receptive group music therapy, or (3) a waitlist control group.

Both music therapy programs were delivered in person over 6 weeks, with one 60-minute session per week facilitated by trained music therapists. The active format emphasized participatory music-making (e.g., singing, rhythmic activities, and group improvisation), while the receptive format focused on guided music listening and reflection.

Participants completed self-report questionnaires at baseline and immediately after the 6-week period assessing positive and negative affect, anxiety symptoms, general health, and perceived social connectedness. The study examined whether the two music therapy approaches led to improvements compared with the waitlist control condition.

Conditions

  • Anxiety
  • Emotional Well-Being
  • Social Connectedness

Interventions

BEHAVIORAL

Active Group Music Therapy

Active group music therapy delivered in person once weekly for 6 weeks (60 minutes per session). Activities included group singing, rhythmic call-and-response, body percussion, simple percussion instruments, and collaborative musical games.

BEHAVIORAL

Receptive Group Music Therapy

Receptive group music therapy delivered in person once weekly for 6 weeks (60 minutes per session). Activities included guided music listening, music-assisted imagery/visualization, reflective writing or moderated discussion, and breathing/relaxation exercises.

Sponsors & Collaborators

  • Yangzhou University

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-02
Primary Completion
2023-06-26
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07393581 on ClinicalTrials.gov